HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cotrufo, M. Articles by Lama, D. Search for Related Content PubMed PubMed Citation Articles by Cotrufo, M. Articles by Lama, D.

European Journal of Cardio-Thoracic Surgery, Vol 5, 300-304, Copyright © 1991 by European Association for Cardio-thoracic Surgery

ARTICLES

Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses

M Cotrufo, TS de Luca, R Calabro, G Mastrogiovanni and D Lama
Institute of Medical and Surgical Cardiology, First Medical School, University of Naples, V. Monaldi Hospital, Italy.

Between January 1987 and December 1989, 20 female patients with one mechanical valve prosthesis (MVP) for at least 1 year postoperatively were studied while on coumarin therapy for the full length of pregnancy. In each case, caesarean section was scheduled for the 38th week. Patients were selected according to the following criteria: (1) prothrombin ratios remaining within the therapeutic range for more than 85% of their total estimations in the previous 12 months with mean daily doses of warfarin less than 5 mg; (2) stable cardiac status; (3) no previous obstetric diseases and (4) full acceptance of the risks involved in the protocol. The patients were in NYHA functional class I or II. Their ages ranged from 23 to 31 years (mean 26 +/- 3). Ten patients had a mitral prosthesis and 10 an aortic prosthesis. Among the 20 mechanical valve prostheses, 10 were Sorin, 6 Starr-Edwards, 2 Bjork- Shiley, and 2 Lillehei-Kaster. Eighteen patients were in sinus rythm, 1 in chronic atrial fibrillation, and 1 had a permanent endocardial pacemaker. Nineteen were delivered by caesarean section: warfarin was withdrawn 48 h before surgery and resumed 24 h thereafter. One patient had premature spontaneous delivery at 36 weeks. The mean prothrombin ratio measured weekly in the 20 patients was 2.06 +/- 0.45 INR, using a mean daily warfarin dose of 4.1 mg +/- 1.63. The mean value of the prothrombin ratio during caesarean section for the 19 patients was 1.23 +/- 0.38 INR. In the 20 live births, the mean birth weight was 2.9 kg +/- 0.40.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. A Geelani, S. Singh, A. Verma, A. Nagesh, V. Betigeri, and M. Nigam Anticoagulation in Patients with Mechanical Valves During Pregnancy Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 30 - 33. [Abstract] [Full Text] [PDF]

				L. Hung and S. H. Rahimtoola Prosthetic Heart Valves and Pregnancy Circulation, March 11, 2003; 107(9): 1240 - 1246. [Full Text] [PDF]

				A. A.M. Al-Lawati, M. Venkitraman, T. Al-Delaime, and J. Valliathu Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 223 - 227. [Abstract] [Full Text] [PDF]

				R. G. Leyh, S. Fischer, A. Ruhparwar, and A. Haverich Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 577 - 579. [Abstract] [Full Text] [PDF]

				W. S. Chan, S. Anand, and J. S. Ginsberg Anticoagulation of Pregnant Women With Mechanical Heart Valves: A Systematic Review of the Literature Arch Intern Med, January 24, 2000; 160(2): 191 - 196. [Abstract] [Full Text] [PDF]

				S S Meschengieser, C G Fondevila, M T Santarelli, and M A Lazzari Anticoagulation in pregnant women with mechanical heart valve prostheses Heart, July 1, 1999; 82(1): 23 - 26. [Abstract] [Full Text] [PDF]